Psychiatric News (12/28) reported that on Dec. 26, “the Food and Drug Administration (FDA) issued a final order…to downgrade the risk category for certain uses of electroconvulsive therapy (ECT).” This particular change was one “for which APA had strongly advocated, saying it could greatly expand access to safe, effective treatment for individuals with serious and persistent psychiatric disorders.
Related Links:
— “FDA Downgrades Risk Category for Certain Uses of ECT, Psychiatric News, December 28, 2018.